Bogle Investment Management’s DexCom DXCM Stock Holding History

Bogle Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,964	Closed	-$1.01M	–	252
2020 Q2	$1.01M	Sell	9,964 -131,828	-93%	-$11.8M	0.17%	165
2020 Q1	$9.54M	Buy	+141,792	New	+$8.82M	1%	43
2019 Q1	–	Sell	-443,328	Closed	-$13.3M	–	311
2018 Q4	$13.3M	Buy	+443,328	New	+$14.1M	1.04%	4
2015 Q4	–	Sell	-520,600	Closed	-$11.2M	–	394
2015 Q3	$11.2M	Buy	520,600 +423,000	+433%	+$9.44M	0.79%	31
2015 Q2	$1.95M	Sell	97,600 -400	-0.4%	-$7.03K	0.15%	182
2015 Q1	$1.53M	Buy	+98,000	New	+$1.48M	0.11%	222
2014 Q2	–	Sell	-360,140	Closed	-$3.72M	–	344
2014 Q1	$3.72M	Sell	360,140 -578,380	-62%	-$5.98M	0.26%	128
2013 Q4	$8.31M	Buy	+938,520	New	+$7.43M	0.7%	51

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bogle Investment Management's DXCM Position: Q3 2020 in Review

Bogle Investment Management sold out of DexCom (DXCM) in Q3 2020, closing a stake of 9,964 shares — an estimated $1.01M sold.

Bogle Investment Management first reported a position in DXCM in Q4 2013 and held it in 8 quarters. The position peaked at $13.3M in Q4 2018. 727 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

Bogle Investment Management reported no remaining DexCom position as of Q3 2020 after selling out during the quarter.
Bogle Investment Management sold 9,964 DexCom shares in Q3 2020, an estimated $1.01M.
Bogle Investment Management first reported a position in DexCom in Q4 2013 and held it in 8 quarters.
Bogle Investment Management's DexCom position peaked at $13.3M in Q4 2018.
727 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on Bogle Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.